Association between hypoglycemia and dementia in patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 116, Issue , 2016, Pages 279-287

  Sheen, Yi Jing ^a   Sheu, Wayne H H ^b,c,d,e  

^a TAICHUNG HOSPITAL   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Cognitive decline; Dementia; Hypoglycemia; Type 2 diabetes

Indexed keywords

DAPAGLIFLOZIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; METFORMIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

BLOOD GLUCOSE MONITORING; BRAIN DISEASE; BRAIN INJURY; BRAIN ISCHEMIA; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH EDUCATION; HIGH RISK POPULATION; HUMAN; HYPOGLYCEMIA; MEDICATION THERAPY MANAGEMENT; MENTAL DETERIORATION; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; POST HYPOGLYCEMIC ENCEPHALOPATHY; REVIEW; RISK FACTOR; STRUCTURE ANALYSIS; ANALYSIS; BLOOD; COGNITION DISORDERS; COMPLICATION;

BLOOD GLUCOSE; COGNITION DISORDERS; DEMENTIA; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; RISK FACTORS;

EID: 84966440635     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2016.04.004     Document Type: Review

References (74)

1. Scheen A.J. Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia. Diabetes Metab 2010, 36(Suppl. 3):S31-S38.
2. Reutens A.T. Epidemiology of diabetic kidney disease. Med Clin North Am 2013, 97(1):1-18.
3. Bordier L., Doucet J., Boudet J., Bauduceau B. Update on cognitive decline and dementia in elderly patients with diabetes. Diabetes Metab 2014, 40(5):331-337.
4. Lu F.P., Lin K.P., Kuo H.K. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One 2009, 4(1):e4144.
5. Cukierman-Yaffe T., Gerstein H.C., Williamson J.D., et al. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 2009, 32(2):221-226.
6. Yaffe K., Falvey C., Hamilton N., et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 2012, 69(9):1170-1175.
7. Barbagallo M., Dominguez L.J. Type 2 diabetes mellitus and Alzheimer's disease. World J Diabetes 2014, 5(6):889-893.
8. Enzinger C., Fazekas F., Matthews P.M., et al. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 2005, 64(10):1704-1711.
9. Munshi M., Grande L., Hayes M., et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 2006, 29(8):1794-1799.
10. Jagielski A.C., Jiang C.Q., Xu L., et al. Glycaemia is associated with cognitive impairment in older adults: the Guangzhou biobank cohort study. Age Ageing 2015, 44(1):65-71.
11. Tournoy J., Lee D.M., Pendleton N., et al. Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: the European male ageing study. Diabetes Metab Res Rev 2010, 26(8):668-676.
12. Chen J.M., Chang C.W., Chang T.H., Hsu C.C., Horng J.T., Sheu W.H. Effects of statins on incident dementia in patients with type 2 DM: a population-based retrospective cohort study in Taiwan. PLoS One 2014, 9(2):e88434.
13. Vischer U.M., Bauduceau B., Bourdel-Marchasson I., et al. A call to incorporate the prevention and treatment of geriatric disorders in the management of diabetes in the elderly. Diabetes Metab 2009, 35(3):168-177.
14. Maraldi C., Volpato S., Penninx B.W., et al. Diabetes mellitus, glycemic control, and incident depressive symptoms among 70- to 79-year-old persons: the health, aging, and body composition study. Arch Intern Med 2007, 167(11):1137-1144.
15. de Galan B.E., Zoungas S., Chalmers J., et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the action in diabetes and vascular disease: preterax and diamicron modified release controlled evaluation (ADVANCE) trial. Diabetologia 2009, 52(11):2328-2336.
16. McGuire L.C., Ford E.S., Ajani U.A. The impact of cognitive functioning on mortality and the development of functional disability in older adults with diabetes: the second longitudinal study on aging. BMC Geriatr 2006, 6:8.
17. Holt P. Taking hypoglycaemia seriously: diabetes, dementia and heart disease. Br J Community Nurs 2011, 16(5):246-249.
18. Morales J., Schneider D. Hypoglycemia. Am J Med 2014, 127(Suppl. 10):S17-S24.
19. Shafiee G., Mohajeri-Tehrani M., Pajouhi M., Larijani B. The importance of hypoglycemia in diabetic patients. J Diabetes Metab Disord 2012, 11(1):17.
20. Cryer P.E. Preventing hypoglycaemia: what is the appropriate glucose alert value?. Diabetologia 2009, 52(1):35-37.
21. Seaquist E.R., Anderson J., Childs B., et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013, 36(5):1384-1395.
22. Lin C.H., Sheu W.H. Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study. J Intern Med 2013, 273(1):102-110.
23. Gerstein H.C., Miller M.E., Byington R.P., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358(24):2545-2559.
24. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360(2):129-139.
25. Aung P.P., Strachan M.W., Frier B.M., Butcher I., Deary I.J., Price J.F. Severe hypoglycaemia and late-life cognitive ability in older people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabet Med 2012, 29(3):328-336.
26. Whitmer R.A., Karter A.J., Yaffe K., Quesenberry C.P., Selby J.V. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009, 301(15):1565-1572.
27. Bree A.J., Puente E.C., Daphna-Iken D., Fisher S.J. Diabetes increases brain damage caused by severe hypoglycemia. Am J Physiol Endocrinol Metab 2009, 297(1):E194-E201.
28. Lacherade J.C., Jacqueminet S., Preiser J.C. An overview of hypoglycemia in the critically ill. J Diabetes Sci Technol 2009, 3(6):1242-1249.
29. Puente E.C., Silverstein J., Bree A.J., et al. Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia. Diabetes 2010, 59(4):1055-1062.
30. Suh S.W., Hamby A.M., Swanson R.A. Hypoglycemia, brain energetics, and hypoglycemic neuronal death. Glia 2007, 55(12):1280-1286.
31. Bauduceau B., Doucet J., Bordier L., Garcia C., Dupuy O., Mayaudon H. Hypoglycaemia and dementia in diabetic patients. Diabetes Metab 2010, 36(Suppl. 3):S106-S111.
32. Chertkow H. Diagnosis and treatment of dementia: introduction. Introducing a series based on the third Canadian Consensus Conference on the diagnosis and treatment of dementia. CMAJ 2008, 178(3):316-321.
33. Regier D.A., Kuhl E.A., Kupfer D.J. The DSM-5: classification and criteria changes. World Psychiatry 2013, 12(2):92-98.
34. Artero S., Ancelin M.L., Portet F., et al. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry 2008, 79(9):979-984.
35. McNay E.C. The impact of recurrent hypoglycemia on cognitive function in aging. Neurobiol Aging 2005, 26(Suppl. 1):76-79.
36. McNay E.C., Cotero V.E. Mini-review: impact of recurrent hypoglycemia on cognitive and brain function. Physiol Behav 2010, 100(3):234-238.
37. Dominguez L.J., Paolisso G., Barbagallo M. Glucose control in the older patient: from intensive, to effective and safe. Aging Clin Exp Res 2010, 22(4):274-280.
38. Duning T., van den Heuvel I., Dickmann A., et al. Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction. Diabetes Care 2010, 33(3):639-644.
39. Bruce D.G., Davis W.A., Casey G.P., et al. Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle diabetes study. Diabetologia 2009, 52(9):1808-1815.
40. Yaffe K., Falvey C.M., Hamilton N., et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 2013, 173(14):1300-1306.
41. McCrimmon R. Glucose sensing during hypoglycemia: lessons from the lab. Diabetes Care 2009, 32(8):1357-1363.
42. Pellerin L. Brain energetics (thought needs food). Curr Opin Clin Nutr Metab Care 2008, 11(6):701-705.
43. Tarczyluk M.A., Nagel D.A., O'Neil J.D., et al. Functional astrocyte-neuron lactate shuttle in a human stem cell-derived neuronal network. J Cereb Blood Flow Metab 2013, 33(9):1386-1393.
44. McNay E.C., Williamson A., McCrimmon R.J., Sherwin R.S. Cognitive and neural hippocampal effects of long-term moderate recurrent hypoglycemia. Diabetes 2006, 55(4):1088-1095.
45. Warren R.E., Frier B.M. Hypoglycaemia and cognitive function. Diabetes Obes Metab 2005, 7(5):493-503.
46. Patrick A.W., Campbell I.W. Fatal hypoglycaemia in insulin-treated diabetes mellitus: clinical features and neuropathological changes. Diabet Med 1990, 7(4):349-354.
47. Fujioka M., Okuchi K., Hiramatsu K.I., Sakaki T., Sakaguchi S., Ishii Y. Specific changes in human brain after hypoglycemic injury. Stroke 1997, 28(3):584-587.
48. Kovalzon V.M., Dorokhov V.B., Loginov V.V. Effects of factors inducing diffuse damage to brain tissue on sleep structure in laboratory rats. Neurosci Behav Physiol 2010, 40(5):507-512.
49. Desouza C.V., Bolli G.B., Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010, 33(6):1389-1394.
50. Fisher B.M., Hepburn D.A., Smith J.G., Frier B.M. Responses of peripheral blood cells to acute insulin-induced hypoglycaemia in humans: effect of alpha-adrenergic blockade. Horm Metab Res Suppl 1992, 26:109-110.
51. Chuo L.J., Sheu W.H., Pai M.C., Kuo Y.M. Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease. Dement Geriatr Cogn Disord 2007, 23(4):251-257.
52. Weng S.C., Shu K.H., Tang Y.J., et al. Progression of cognitive dysfunction in elderly chronic kidney disease patients in a veteran's institution in central Taiwan: a 3-year longitudinal study. Intern Med 2012, 51(1):29-35.
53. Skyler J.S., Bergenstal R., Bonow R.O., et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009, 32(1):187-192.
54. Williams S.A., Shi L., Brenneman S.K., Johnson J.C., Wegner J.C., Fonseca V. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients. J Diabetes Complications 2012, 26(5):399-406.
55. Bron M., Marynchenko M., Yang H., Yu A.P., Wu E.Q. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs. Postgrad Med 2012, 124(1):124-132.
56. Punthakee Z., Miller M.E., Launer L.J., et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012, 35(4):787-793.
57. Boutati E.I., Raptis S.A. Self-monitoring of blood glucose as part of the integral care of type 2 diabetes. Diabetes Care 2009, 32(Suppl. 2):S205-S210.
58. Abbatecola A.M., Rizzo M.R., Barbieri M., et al. Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics. Neurology 2006, 67(2):235-240.
59. Alagiakrishnan K., Sankaralingam S., Ghosh M., Mereu L., Senior P. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease. Discov Med 2013, 16(90):277-286.
60. Hwang I.K., Kim I.Y., Joo E.J., et al. Metformin normalizes type 2 diabetes-induced decrease in cell proliferation and neuroblast differentiation in the rat dentate gyrus. Neurochem Res 2010, 35(4):645-650.
61. Duarte A.I., Candeias E., Correia S.C., Santos R.X., Carvalho C., Cardoso S., et al. Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration. Biochim Biophys Acta 2013, 1832(4):527-541.
62. Kosaraju J., Madhunapantula S.V., Chinni S., et al. Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease. Behav Brain Res 2014, 267:55-65.
63. Shaikh S., Danish Rizvi S.M., Shakil S., Riyaz S., Biswas D., Jahan R. Forxiga (Dapagliflozin): plausible role in the treatment of diabetes associated neurological disorders. Biotechnol Appl Biochem 2014.
64. Brink S.J., Miller M., Moltz K.C. Education and multidisciplinary team care concepts for pediatric and adolescent diabetes mellitus. J Pediatr Endocrinol Metab 2002, 15(8):1113-1130.
65. del Ser T., Sanchez-Sanchez F., Garcia de Yebenes M.J., Otero A., Munoz D.G. Validation of the seven-minute screen neurocognitive battery for the diagnosis of dementia in a Spanish population-based sample. Dement Geriatr Cogn Disord 2006, 22(5-6):454-464.
66. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Breteler M.M. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 1999, 53(9):1937-1942.
67. Luchsinger J.A., Tang M.X., Stern Y., Shea S., Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001, 154(7):635-641.
68. Peila R., Rodriguez B.L., Launer L.J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes 2002, 51(4):1256-1262.
69. Hassing L.B., Johansson B., Nilsson S.E., et al. Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population-based study of the oldest old. Int Psychogeriatr 2002, 14(3):239-248.
70. MacKnight C., Rockwood K., Awalt E., McDowell I. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian study of health and aging. Dement Geriatr Cogn Disord 2002, 14(2):77-83.
71. Xu W.L., Qiu C.X., Wahlin A., Winblad B., Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology 2004, 63(7):1181-1186.
72. Akomolafe A., Beiser A., Meigs J.B., et al. Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham study. Arch Neurol 2006, 63(11):1551-1555.
73. Hayden K.M., Zandi P.P., Lyketsos C.G., et al. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord 2006, 20(2):93-100.
74. Irie F., Fitzpatrick A.L., Lopez O.L., et al. Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the cardiovascular health study cognition study. Arch Neurol 2008, 65(1):89-93.